These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

72 related items for PubMed ID: 22018191

  • 1. Adverse events of intravenous glucocorticoid pulse therapy in inflammatory diseases: a meta-analysis.
    Smits NA, Duru N, Bijlsma JW, Jacobs JW.
    Clin Exp Rheumatol; 2011; 29(5 Suppl 68):S85-92. PubMed ID: 22018191
    [Abstract] [Full Text] [Related]

  • 2. Monitoring adverse events of low-dose glucocorticoid therapy: EULAR recommendations for clinical trials and daily practice.
    van der Goes MC, Jacobs JW, Boers M, Andrews T, Blom-Bakkers MA, Buttgereit F, Caeyers N, Cutolo M, Da Silva JA, Guillevin L, Kirwan JR, Rovensky J, Severijns G, Webber S, Westhovens R, Bijlsma JW.
    Ann Rheum Dis; 2010 Nov; 69(11):1913-9. PubMed ID: 20693273
    [Abstract] [Full Text] [Related]

  • 3. Toward safer treatment with glucocorticoids: via patient and rheumatologist perspectives to recommendations on monitoring for adverse events.
    van der Goes MC, Jacobs JW, Bijlsma JW.
    Clin Exp Rheumatol; 2011 Nov; 29(5 Suppl 68):S116-20. PubMed ID: 22018196
    [Abstract] [Full Text] [Related]

  • 4. The safety of low-dose glucocorticoids in rheumatic diseases.
    Hwang YG, Saag K.
    Clin Exp Rheumatol; 2011 Nov; 29(5 Suppl 68):S104-12. PubMed ID: 22018194
    [Abstract] [Full Text] [Related]

  • 5. The safety of low-dose glucocorticoids in rheumatic diseases: results from observational studies.
    Hwang YG, Saag K.
    Neuroimmunomodulation; 2015 Nov; 22(1-2):72-82. PubMed ID: 25228230
    [Abstract] [Full Text] [Related]

  • 6. Adverse events of low- to medium-dose oral glucocorticoids in inflammatory diseases: a meta-analysis.
    Hoes JN, Jacobs JW, Verstappen SM, Bijlsma JW, Van der Heijden GJ.
    Ann Rheum Dis; 2009 Dec; 68(12):1833-8. PubMed ID: 19066177
    [Abstract] [Full Text] [Related]

  • 7. A Survey of Glucocorticoid Adverse Effects and Benefits in Rheumatic Diseases: The Patient Perspective.
    Black RJ, Goodman SM, Ruediger C, Lester S, Mackie SL, Hill CL.
    J Clin Rheumatol; 2017 Dec; 23(8):416-420. PubMed ID: 28926469
    [Abstract] [Full Text] [Related]

  • 8. Once-monthly oral ibandronate provides significant improvement in bone mineral density in postmenopausal women treated with glucocorticoids for inflammatory rheumatic diseases: a 12-month, randomized, double-blind, placebo-controlled trial.
    Hakala M, Kröger H, Valleala H, Hienonen-Kempas T, Lehtonen-Veromaa M, Heikkinen J, Tuomiranta T, Hannonen P, Paimela L, ONCE trial group.
    Scand J Rheumatol; 2012 Aug; 41(4):260-6. PubMed ID: 22803768
    [Abstract] [Full Text] [Related]

  • 9. EULAR evidence-based and consensus-based recommendations on the management of medium to high-dose glucocorticoid therapy in rheumatic diseases.
    Duru N, van der Goes MC, Jacobs JW, Andrews T, Boers M, Buttgereit F, Caeyers N, Cutolo M, Halliday S, Da Silva JA, Kirwan JR, Ray D, Rovensky J, Severijns G, Westhovens R, Bijlsma JW.
    Ann Rheum Dis; 2013 Dec; 72(12):1905-13. PubMed ID: 23873876
    [Abstract] [Full Text] [Related]

  • 10. Quantifying cutaneous adverse effects of systemic glucocorticoids in patients with rheumatoid arthritis: a cross-sectional cohort study.
    Amann J, Wessels AM, Breitenfeldt F, Huscher D, Bijlsma JWJ, Jacobs JWG, Buttgereit F.
    Clin Exp Rheumatol; 2017 Dec; 35(3):471-476. PubMed ID: 28094753
    [Abstract] [Full Text] [Related]

  • 11. [Glucocorticoids in rheumatic diseases - what is the optimal dose?].
    Krause D.
    Dtsch Med Wochenschr; 2012 Sep; 137(36):1751-4. PubMed ID: 22933199
    [Abstract] [Full Text] [Related]

  • 12. Relationship between glucocorticoid dose and adverse events in systemic lupus erythematosus: data from a randomized clinical trial.
    Emamikia S, Gentline C, Chatzidionysiou K, Arnaud L, van Vollenhoven R.
    Scand J Rheumatol; 2018 Mar; 47(2):131-140. PubMed ID: 28862513
    [Abstract] [Full Text] [Related]

  • 13. [Current aspects of glucocorticoid therapy of rheumatic diseases. Pulse-therapy].
    Solovyev SK, Ivanova MM.
    Ter Arkh; 2009 Mar; 81(6):73-8. PubMed ID: 19663198
    [Abstract] [Full Text] [Related]

  • 14. Treatment of giant cell arteritis using induction therapy with high-dose glucocorticoids: a double-blind, placebo-controlled, randomized prospective clinical trial.
    Mazlumzadeh M, Hunder GG, Easley KA, Calamia KT, Matteson EL, Griffing WL, Younge BR, Weyand CM, Goronzy JJ.
    Arthritis Rheum; 2006 Oct; 54(10):3310-8. PubMed ID: 17009270
    [Abstract] [Full Text] [Related]

  • 15. Effect of once-daily fluticasone furoate/vilanterol on 24-hour pulmonary function in patients with chronic obstructive pulmonary disease: a randomized, three-way, incomplete block, crossover study.
    Boscia JA, Pudi KK, Zvarich MT, Sanford L, Siederer SK, Crim C.
    Clin Ther; 2012 Aug; 34(8):1655-66.e5. PubMed ID: 22789766
    [Abstract] [Full Text] [Related]

  • 16. Safety of medium- to long-term glucocorticoid therapy in rheumatoid arthritis: a meta-analysis.
    Ravindran V, Rachapalli S, Choy EH.
    Rheumatology (Oxford); 2009 Jul; 48(7):807-11. PubMed ID: 19447767
    [Abstract] [Full Text] [Related]

  • 17. Perioperative glucocorticoids in hip and knee surgery - benefit vs. harm? A review of randomized clinical trials.
    Lunn TH, Kehlet H.
    Acta Anaesthesiol Scand; 2013 Aug; 57(7):823-34. PubMed ID: 23581549
    [Abstract] [Full Text] [Related]

  • 18. Patient and rheumatologist perspectives on glucocorticoids: an exercise to improve the implementation of the European League Against Rheumatism (EULAR) recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases.
    van der Goes MC, Jacobs JW, Boers M, Andrews T, Blom-Bakkers MA, Buttgereit F, Caeyers N, Choy EH, Cutolo M, Da Silva JA, Guillevin L, Holland M, Kirwan JR, Rovensky J, Saag KG, Severijns G, Webber S, Westhovens R, Bijlsma JW.
    Ann Rheum Dis; 2010 Jun; 69(6):1015-21. PubMed ID: 19762359
    [Abstract] [Full Text] [Related]

  • 19. Glucocorticoids in paediatric rheumatology.
    Ravelli A, Lattanzi B, Consolaro A, Martini A.
    Clin Exp Rheumatol; 2011 Jun; 29(5 Suppl 68):S148-52. PubMed ID: 22018202
    [Abstract] [Full Text] [Related]

  • 20. Statin-related adverse events: a meta-analysis.
    Silva MA, Swanson AC, Gandhi PJ, Tataronis GR.
    Clin Ther; 2006 Jan; 28(1):26-35. PubMed ID: 16490577
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.